These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10689787)

  • 1. Use of CpG DNA for enhancing specific immune responses.
    Davis HL
    Curr Top Microbiol Immunol; 2000; 247():171-83. PubMed ID: 10689787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen.
    Davis HL; Weeratna R; Waldschmidt TJ; Tygrett L; Schorr J; Krieg AM
    J Immunol; 1998 Jan; 160(2):870-6. PubMed ID: 9551923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CpG DNA is an effective oral adjuvant to protein antigens in mice.
    McCluskie MJ; Weeratna RD; Krieg AM; Davis HL
    Vaccine; 2000 Nov; 19(7-8):950-7. PubMed ID: 11115721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunology of DNA vaccines: CpG motifs and antigen presentation.
    Manders P; Thomas R
    Inflamm Res; 2000 May; 49(5):199-205. PubMed ID: 10893042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological activity of immunostimulatory CpG DNA motifs in domestic animals.
    Mutwiri G; Pontarollo R; Babiuk S; Griebel P; van Drunen Littel-van den Hurk S; Mena A; Tsang C; Alcon V; Nichani A; Ioannou X; Gomis S; Townsend H; Hecker R; Potter A; Babiuk LA
    Vet Immunol Immunopathol; 2003 Jan; 91(2):89-103. PubMed ID: 12543546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of CpG dinucleotides in DNA vaccines.
    Krieg AM; Yi AK; Schorr J; Davis HL
    Trends Microbiol; 1998 Jan; 6(1):23-7. PubMed ID: 9481820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attachment of class B CpG ODN onto DOTAP/DC-chol liposome in nasal vaccine formulations augments antigen-specific immune responses in mice.
    Tada R; Muto S; Iwata T; Hidaka A; Kiyono H; Kunisawa J; Aramaki Y
    BMC Res Notes; 2017 Jan; 10(1):68. PubMed ID: 28126014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CpG ODN can re-direct the Th bias of established Th2 immune responses in adult and young mice.
    Weeratna RD; Brazolot Millan CL; McCluskie MJ; Davis HL
    FEMS Immunol Med Microbiol; 2001 Dec; 32(1):65-71. PubMed ID: 11750224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CpG oligodeoxynucleotide vaccination suppresses IgE induction but may fail to down-regulate ongoing IgE responses in mice.
    Peng Z; Wang H; Mao X; HayGlass KT; Simons FE
    Int Immunol; 2001 Jan; 13(1):3-11. PubMed ID: 11133829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA vaccines in sheep: CTLA-4 mediated targeting and CpG motifs enhance immunogenicity in a DNA prime/protein boost strategy.
    Kennedy NJ; Spithill TW; Tennent J; Wood PR; Piedrafita D
    Vaccine; 2006 Feb; 24(7):970-9. PubMed ID: 16242220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CpG motifs as immune adjuvants.
    Klinman DM; Barnhart KM; Conover J
    Vaccine; 1999 Jan; 17(1):19-25. PubMed ID: 10078603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intranasal immunization of mice with CpG DNA induces strong systemic and mucosal responses that are influenced by other mucosal adjuvants and antigen distribution.
    McCluskie MJ; Weeratna RD; Davis HL
    Mol Med; 2000 Oct; 6(10):867-77. PubMed ID: 11126201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of CpG in DNA vaccines.
    McCluskie MJ; Weeratna RD; Davis HL
    Springer Semin Immunopathol; 2000; 22(1-2):125-32. PubMed ID: 10944807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced tumor-specific long-term immunity of hemagglutinating [correction of hemaggluttinating] virus of Japan-mediated dendritic cell-tumor fused cell vaccination by coadministration with CpG oligodeoxynucleotides.
    Hiraoka K; Yamamoto S; Otsuru S; Nakai S; Tamai K; Morishita R; Ogihara T; Kaneda Y
    J Immunol; 2004 Oct; 173(7):4297-307. PubMed ID: 15383558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human immunodeficiency virus (HIV)-specific immune responses are generated with the simultaneous vaccination of a gp120-depleted, whole-killed HIV-1 immunogen with cytosine-phosphorothioate-guanine dinucleotide immunostimulatory sequences of DNA.
    Moss RB; Diveley J; Jensen FC; Gouveia E; Carlo DJ
    J Hum Virol; 2001; 4(1):39-43. PubMed ID: 11213932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral, intrarectal and intranasal immunizations using CpG and non-CpG oligodeoxynucleotides as adjuvants.
    McCluskie MJ; Davis HL
    Vaccine; 2000 Oct; 19(4-5):413-22. PubMed ID: 11027803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmids enriched with CpG motifs activate human peripheral blood mononuclear cells in vitro and enhance th-1 immune responses to hepatitis B surface antigen in mice.
    Chen Z; Cao J; Liao X; Ke J; Zhu S; Zhao P; Qi Z
    Viral Immunol; 2011 Jun; 24(3):199-209. PubMed ID: 21668361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization of aged mice with a pneumococcal conjugate vaccine combined with an unmethylated CpG-containing oligodeoxynucleotide restores defective immunoglobulin G antipolysaccharide responses and specific CD4+-T-cell priming to young adult levels.
    Sen G; Chen Q; Snapper CM
    Infect Immun; 2006 Apr; 74(4):2177-86. PubMed ID: 16552048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of immunostimulatory CpG-DNA and its application to tuberculosis vaccine development.
    Yamamoto S; Yamamoto T; Nojima Y; Umemori K; Phalen S; McMurray DN; Kuramoto E; Iho S; Takauji R; Sato Y; Yamada T; Ohara N; Matsumoto S; Goto Y; Matsuo K; Tokunaga T
    Jpn J Infect Dis; 2002 Apr; 55(2):37-44. PubMed ID: 12082305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CpG DNA augments the immunogenicity of plasmid DNA vaccines.
    Klinman DM; Ishii KJ; Verthelyi D
    Curr Top Microbiol Immunol; 2000; 247():131-42. PubMed ID: 10689784
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.